Literature DB >> 19142157

The pleiotropic effects of ethacrynic acid.

John C Somberg1, Janos Molnar.   

Abstract

Ethacrynic acid (EC), an effective loop diuretic especially in patients allergic to sulfa-containing drugs, possesses a number of potentially useful actions in addition to the inhibition of the Na⁺-K⁺-2Cl⁻ kidney symport. Inhibition of the enzyme glutathione S-transferase plays an important role in reducing chemotherapy drug resistance. Chemical modifications of EC increase inhibition of glutathione S-transferase and reduce toxicity due to diuretic action (hypotension and hypovolemia). This work may lead to effective therapies in reducing chemotherapy resistance in cancer chemotherapeutics. In addition, EC or conjurers may be a radiation enhancer, an anti-inflammatory agent, or a treatment for glaucoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19142157     DOI: 10.1097/MJT.0b013e3181961264

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  6 in total

1.  Ethacrynic acid and cinnamic acid combination exhibits selective anticancer effects on K562 chronic myeloid leukemia cells.

Authors:  Münevver Yenigül; İsmail Akçok; Emel Başak Gencer Akçok
Journal:  Mol Biol Rep       Date:  2022-05-18       Impact factor: 2.742

Review 2.  Glutathione metabolism and Parkinson's disease.

Authors:  Michelle Smeyne; Richard Jay Smeyne
Journal:  Free Radic Biol Med       Date:  2013-05-08       Impact factor: 7.376

3.  Chemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like Cells.

Authors:  Maria Zeniou; Marie Fève; Samir Mameri; Jihu Dong; Christophe Salomé; Wanyin Chen; Elias A El-Habr; Fanny Bousson; Mohamadou Sy; Julie Obszynski; Alexandre Boh; Pascal Villa; Suzana Assad Kahn; Bruno Didier; Dominique Bagnard; Marie-Pierre Junier; Hervé Chneiweiss; Jacques Haiech; Marcel Hibert; Marie-Claude Kilhoffer
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

4.  Decreased glutathione biosynthesis contributes to EGFR T790M-driven erlotinib resistance in non-small cell lung cancer.

Authors:  Hongde Li; William Stokes; Emily Chater; Rajat Roy; Elza de Bruin; Yili Hu; Zhigang Liu; Egbert F Smit; Guus Jje Heynen; Julian Downward; Michael J Seckl; Yulan Wang; Huiru Tang; Olivier E Pardo
Journal:  Cell Discov       Date:  2016-09-27       Impact factor: 10.849

5.  Itaconic acid hybrids as potential anticancer agents.

Authors:  Ivana Perković; Maja Beus; Dominique Schols; Leentje Persoons; Branka Zorc
Journal:  Mol Divers       Date:  2020-10-11       Impact factor: 3.364

6.  Asymmetric Primaquine and Halogenaniline Fumardiamides as Novel Biologically Active Michael Acceptors.

Authors:  Zrinka Rajić; Maja Beus; Hana Michnová; Josipa Vlainić; Leentje Persoons; Ivan Kosalec; Josef Jampílek; Dominique Schols; Toma Keser; Branka Zorc
Journal:  Molecules       Date:  2018-07-14       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.